IX vs NMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
IX
NMR
Investment Advisor Scores
NMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IX | NMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 14.245 | 15.3846 | IX |
| PEG Ratio | 2.7166 | 0.8146 | NMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.2% | 17.9% | NMR |
| Earnings Growth | 263.3% | 13.6% | IX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.5/100 | 45.5/100 | NMR |
| Profit Margin | 29.7% | 17.1% | IX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | NMR |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IX
MarkdownPrice below a falling SMA50 (slope -3.5%), weak momentum, RSI 31
NMR
NeutralMixed signals - no dominant trend phase, RSI 55
Fundamentals Snapshot
| Metric | IX | NMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.4 | 13.0 |
| Trailing P/E | 6.0 | 10.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.2% |
| Gross Margin | 0.4% | 0.8% |
| Operating Margin | 0.2% | 0.2% |
| EPS | 5.47 | 0.87 |
| Dividend Yield | 0.03% | 0.03% |